---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-238135"
form_type: "8-K"
ticker: "STIM"
cik: "0001227636"
company_name: "Neuronetics, Inc."
filed_at: "2021-08-06T23:59:59+00:00"
generated_at: "2026-06-29T20:00:58.995676+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Neuronetics appoints Megan Rosengarten to Board of Directors, effective August 2, 2021

## Summary
- Megan Rosengarten appointed as director and member of the Compensation Committee.
- Rosengarten currently serves as President of Surgical Robotics at Medtronic.
- Board expands to eight members; Rosengarten's term expires at 2022 annual meeting.
- She qualifies as independent under SEC and Nasdaq standards.
- No arrangements or family relationships with officers; standard director compensation applies.

## SEC filing metadata
- accession: 0001193125-21-238135
- form_type: 8-K
- ticker: STIM
- cik: 0001227636
- company_name: Neuronetics, Inc.
- filed_at: 2021-08-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1227636/000119312521238135/0001193125-21-238135-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1227636/000119312521238135/d216984d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-238135
- JSON: https://secwatch.observer/filing/0001193125-21-238135.json
- Plain text: https://secwatch.observer/filing/0001193125-21-238135.txt

## Key facts
- Executive change
  Megan Rosengarten was appointed as Director at Neuronetics, Inc..
  - Action: appointed
  - Role: Director
  source text: appointed Megan Rosengarten as a director and member of the Board’s Compensation Committee.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1227636/000119312521238135/0001193125-21-238135-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.